Health Encyclopedia

Osler-Weber-Rendu syndrome

Definition

Osler-Weber-Rendu syndrome is an inherited disorder of the blood vessels, which can cause excessive bleeding. The syndrome is also called hereditary hemorrhagic telangiectasia, or HHT.

Alternative Names

Hereditary hemorrhagic telangiectasia

Causes, incidence, and risk factors

Osler-Weber-Rendu syndrome is inherited as an autosomal dominant trait. The condition can affect males or females of any ethnic or racial group.

Children with this syndrome develop red or reddish-purple collections of abnormal blood vessels called telangiectases.

The syndrome is genetic, which means it results from a broken or missing gene. Scientists have identified some of the genes involved, but do not know exactly how the gene defects lead to the abnormal blood vessels seen in persons with this syndrome.

Symptoms

Frequent nosebleeds in children may be an early symptom.

Telangiectases may not appear until puberty. They can bleed easily and may be seen on the tongue, lips, nasal mucosa, face, ears, fingertips, nails, whites of the eyes, and skin.

There may be GI bleeding, including loss of blood in stool or dark black stools.

Bleeding into the brain may cause symptoms such as seizures or unexplained, small strokes. Severe bleeding can be deadly.

Some patients only discover that they have this condition when they cough up blood and a chest x-ray shows a spot on the lung called an arteriovenous malformation (AVM). Large or multiple AVMs can cause shortness of breath.

A port wine stain is occasionally present.

Signs and tests

An experienced health care provider can detect telangiectases during a physical examination. There is often a family history of hereditary hemorrhagic telangiectasia.

Other signs include:

Chest x-ray may show a "spot on the lung" (arteriovenous malformation).
Echocardiogram may show heart failure.
Blood tests may reveal iron deficiency anemia.
Special blood gas tests may show decreased levels of oxygen in blood.
Endoscopy may show abnormal blood vessels that bleed easily in the throat, bowels, or airways.
Hepatomegaly may occur if there are abnormal blood vessels in the liver.

Genetic testing may be available for mutations in the endoglin or ALK1 genes.

Treatment

Surgey is needed to treat bleeding in some areas. Frequent or heavy nosebleeds may be treated with electrocautery or laser surgery.

Endovascular embolization may be needed to treat abnormal blood vessels in the brain and other parts of the body.

Some patients respond to estrogen therapy, which can reduce bleeding episodes. Blood-thinning medications should be avoided. Some patients may need to take antibiotics before having dental work or surgery. Ask your doctor what precautions you should take.

Support Groups

HHT Foundation International -- www.hht.org

Expectations (prognosis)

Unless there is life-threatening intracranial hemorrhage, persons with this syndrome can live a completely normal lifespan.

Complications

Internal bleeding
Heart failure
Shortness of breath
High blood pressure in the lungs (pulmonary hypertension)

Calling your health care provider

Call your health care provider if your child has frequent nose bleeds or other signs of this disease.

Prevention

Genetic counseling is recommended for prospective parents with a family history of hereditary hemorrhagic telangiectasia. Certain types of strokes and heart failure can be prevented with medical treatments.

References

Azuma H: Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia. J Med Invest. 2000 Aug; 47(3-4): 81-90.

Faughnan ME, Hyland RH, Nanthakumar K, Redelmeier DA: Screening in hereditary hemorrhagic telangiectasia patients. Chest. 2000 Aug; 118(2): 566-7.

Review Date:5/16/2007
Reviewed By:Brian Kirmse, MD, Mount Sinai School of Medicine, Department of Human Genetics, New York, NY. Review provided by VeriMed Healthcare Network.

ADAM Quality A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The Agency for Health Care Administration (Agency) and this website do not claim the information on, or referred to by, this site is error free. This site may include links to websites of other government agencies or private groups. Our Agency and this website do not control such sites and are not responsible for their content. Reference to or links to any other group, product, service, or information does not mean our Agency or this website approves of that group, product, service, or information.

Additionally, while health information provided through this website may be a valuable resource for the public, it is not designed to offer medical advice. Talk with your doctor about medical care questions you may have.